pomalidomide has been researched along with Paraproteinemias in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arbab, A; Cotteret, S; Ghez, D; Marzac, C; Saada, V | 1 |
1 other study(ies) available for pomalidomide and Paraproteinemias
| Article | Year |
|---|---|
Plasma cell dedifferentiation in refractory multiple myeloma.
Topics: Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cell Dedifferentiation; Dexamethasone; Flow Cytometry; Humans; Immunophenotyping; Male; Multiple Myeloma; Mutation; Myelodysplastic Syndromes; Paraproteinemias; Plasma Cells; Thalidomide; Treatment Failure; Tumor Suppressor Protein p53 | 2021 |